1.. Introduction {#S0001}
================

Gastric acid plays an essential role in the digestion of protein by converting pepsinogen to the active form, pepsin. It also prevents against enteric infection, bacterial overgrowth and facilitates the absorption of vitamin B12, non-heme iron, and medications such as calcium and thyroxin \[[1](#CIT0001)\]. Consequences of hypochlorhydria have been well defined in the literature: (1) Osteoporosis and Hip Fracture \[[2](#CIT0002)\]; (2) Hospital acquired pneumonia and community acquired pneumonia \[[3](#CIT0003),[4](#CIT0004)\]; (3) Clostridium difficile infection \[[5](#CIT0005)\]; (4) Vitamin B 12 deficiency \[[6](#CIT0006)\]; (5) Alteration in the lower intestinal microflora \[[7](#CIT0007)\]; (6) Various forms of kidney injury have also been linked to the PPIs use such as acute allergic interstitial nephritis, acute kidney injury, increased incidence of chronic kidney disease and progression to end stage renal disease \[[8](#CIT0008)\].

PPIs come under the category of one of the most commonly prescribed medications with esmoprazole and omeprazole making the list of the top 10 drugs by total prescriptions in 2015 and 2016 \[[9](#CIT0009),[10](#CIT0010)\].

Acid suppression therapy (AST) mainly consist of Proton Pump Inhibitors (PPIs) and H2 Receptor Antagonists (H2RA). AST is one of the most commonly prescribed classes of medications in hospitalized patients. Studies have demonstrated that many patients who are placed on AST do not have an appropriate indication \[[11](#CIT0011)\]. Additionally, once initiated during hospitalization, there is a high likelihood these medications will be continued at the time of the discharge \[[12](#CIT0012)\]. Accepted indications have been outlined by the USA Food and Drug Administration (USFDA) and the American Society of Health System Pharmacists (ASHP) for the use of PPIs ([Tables 1](#T0001) and [2](#T0002)) \[[13](#CIT0013)--[17](#CIT0017)\].10.1080/20009666.2019.1571881-T0001Table 1.USFDA approved indications for Proton Pump Inhibitors1Healing of erosive esophagitis2Maintenance of healing of erosive esophagitis3Treatment of gastric ulcer4Treatment of duodenal ulcer5Healing of Non-steroidal anti-inflammatory (NSAID) induced gastric ulcer6Symptomatic gastroesophageal reflux disease7Risk reduction of NSAID associated gastric ulcer8Risk reduction of upper gastrointestinal bleeding in critically ill patients9Acid Hypersecretory states such as Zollinger -- Ellison Syndrome10Helicobacter pylori eradication in combination with antibiotics[^1]10.1080/20009666.2019.1571881-T0002Table 2.ASHP Defined indications for Stress Ulcer Prophylaxis1Mechanical Ventilation for \> 48 hours2Coagulopathy (i.e., platelet count \< 50,000; international normalized ratio (INR) \> 1.5, or an activated partial thromboplastic time (aPTT) \> 2 times control3Glasgow coma score of ≤ 104Thermal injury to \> 35% of the body surface area5History of gastrointestinal ulceration or bleeding within 1 year of admission6Multiple trauma (injury severity of ≥ 16)7Spinal Cord Injury8Transplantation perioperatively in the ICU9Hepatic Failure10Two or more of the following risk factors: sepsis, ICU stay of greater than 1 week, occult bleeding lasting at least 6 days and high dose corticosteroids (\> 250 mg/day of hydrocortisone or its equivalent)11Partial Hepatectomy[^2]

Furthermore, geriatric patients are at greater risks for adverse reactions to PPI (i.e., Clostridium difficile infection, pneumonia, etc.) and polypharmacy. It is currently unknown how often geriatric patients are prescribed AST in the inpatient setting. Therefore, we aimed to assess the use of AST in hospitalized geriatric patients. In addition, we also created an educational intervention to attempt to improve the appropriateness of AST prescribing in this setting.

2.. Methods {#S0002}
===========

2.1.. Study design {#S0002-S2001}
------------------

Using a pretest-posttest design, we established a historical cohort by performing a retrospective chart review conducted at St. Mary Mercy Hospital Livonia, a 304-bed acute care hospital located in Southeastern Michigan. Charts of all patients admitted to the medicine teaching service between August 25th to October 31st, 2014 were reviewed. Inclusion Criteria were defined as: (1) Age ≥ 65 years old; (2) Acid suppression therapy-initiated in the hospital; and (3) Patients admitted to the medicine teaching services. Intensive care unit (ICU) and surgical patients as well as patients who were already on acid suppression drugs prior to their hospitalization were excluded. The primary objective was defined as the prevalence of AST in geriatric inpatient population in a non-critical setting before and after educational intervention.

2.2.. Educational intervention {#S0002-S2002}
------------------------------

Educational interventions used which consisted of: (1) Distributing AST guidelines pocket cards to residents; (2) Posting the appropriate indications of AST on the resident work stations; (3) Lectures about the appropriate indications were provided at the beginning of the academic year and at the beginning of every month; and (4) Gastroenterologists and chief residents provided noon didactic sessions on AST.

2.3.. Statistical analysis {#S0002-S2003}
--------------------------

Data analysis was performed using SPSS version 19 for Windows (SPSS Incorporation, Chicago, IL). Significant tests of equality of two proportions were carried using the two tail Fischer's exact test using the graph pad. Student's t-test was used for comparing means of the continuous variables.

3.. Results {#S0003}
===========

Before the educational intervention, we identified 65% of the geriatric patients who were prescribed inpatient AST when it was not indicated. Thirteen percent of patients were discharged on AST without any indication. Based on these results, we decided to implement Acid Suppression Quality Improvement Initiative among patients of geriatric age group. Five hundred and twenty-five patients (≥ 65 years old) were admitted to the medicine teaching services during our study. Out of these, 112 (21%) patients met the inclusion criterion. After the educational intervention, the inappropriate use of AST decreased from 65% to 45% (P \< 0.05) ([Figure 1](#F0001)). The proportion of patients receiving inappropriate stress ulcer prophylaxis before and after the intervention decreased from 54% to 44% (P = 0.16) ([Figure 2](#F0002)).10.1080/20009666.2019.1571881-F0001Figure 1.AST use before and after the educational intervention.10.1080/20009666.2019.1571881-F0002Figure 2.Percentage of patients receiving stress ulcer prophylaxis before and after intervention.

4.. Discussions {#S0004}
===============

Many practitioners view AST as harmless and there is an overestimation of the risk of stress related mucosal ulceration among the hospitalized patients. The perception that it lacks drug interactions, adverse effects and blanket orders to place all patients on stress ulcer prophylaxis are important reasons for their over use. Various patterns and predictors have been described in the literature for their overuse such as non-academic hospitalist staff, gastrointestinal prophylaxis checkbox in the order set, multiple handoffs, length of hospitalization, female sex, etc \[[12](#CIT0012),[18](#CIT0018)\].

Effects of educating prescribers in the hospital has shown mixed results with some benefit on intermediate outcome parameters with multifaceted interventions \[[19](#CIT0019)\]. This study does highlight that simple educational interventions can lead to positive outcomes. This educational intervention decreased the inappropriate use of AST from 65% to 45%. The proportion of patients receiving inappropriate stress ulcer prophylaxis also decreased from 54% to 44%. There were several limitations to this study as well: (1) It was a retrospective design; (2) Only a single teaching hospital was included; (3) It included only geriatric patient population and; (4) Short follow up post intervention. However, this educational intervention was found to be cost-effective and feasible. This intervention failed to increase the appropriate rate of AST prescription being close to 100% as it was solely an educational intervention trying to improvise the prescribing behavior for the AST. This directs us further on other potential interventions such as continued education of not only the residents but also educating pharmacists, nursing staff, other healthcare providers, minimizing empiric trials of PPIs, creating institutional protocols and using order sets that will prompt to enter the indication while ordering AST.

5.. Conclusion {#S0005}
==============

This study concludes that there continues to be significant overuse of AST in hospitalized geriatric patients. Research has shown the inappropriate use of AST may lead to unnecessary harm and increased healthcare costs. This Quasi-experiment pretest/posttest design demonstrated that repeated education could decrease the unnecessary use of AST but have limited effects. Further systemic studies should assess other interventions such as alerts in the electronic medical records, educating other healthcare staff to assist in the appropriateness in the AST.
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